Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
DoubleVerify Launches AI-Powered Brand Suitability Reporting for YouTube Audio Ads Campaigns, Expanding Transparency in Listening-First Environments
-
Chaince Digital Extends the “Chain” Beyond Earth: Board Approves Initiative to Explore Space-Based AI Infrastructure
-
Abacus Global Management to Participate in the Northland Growth Conference 2026
-
U.S. commercial insurance rates increase 2.5%, extending moderating trend
-
HERE WeGo brings real-time traffic intel to soccer fans across North America
-
Vistra appoints Raimundo Diaz as Executive Vice President, Americas, to lead corporate services growth across the region
-
Pasqal Inaugurates Italy’s First Neutral-Atom Quantum Computer, Third Pasqal System in Europe
-
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
-
Michelin | Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
Form 8.3 - Picton Property Income Limited
-
Form 8.3 - LondonMetric Property Plc & Schroder REIT Ltd
-
Nova Complex Showcases European Green Infrastructure Strategy at Datacloud Global Congress 2026
-
Umbrella Lab Announces Documentation And Traceability Update For Bromantane Reference Material
-
3 E Network Enters Strategic Framework Agreement with California-Based Aladdin Alaris AI to Explore Next-Generation Healthcare and Eldercare Robotics
-
Net Asset Value(s)
-
The Edge Negotiation Group Launches Deal/Spar, an AI-Powered Negotiation Simulator for Voice and Text-Based Practice
-
The Hemp Tax: Why Industrial Hemp Can’t Afford to Sit This One Out[
-
Midland Identifies Several Lake Bottom Copper Anomalies from Its New High-Resolution Survey Completed on the Lac Bernard Project
-
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
-
Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026
-
North American Niobium to Fly Airborne Survey Over Four Québec Properties
-
FLUENT Provides Management Update
-
QGold Provides Update on Acceleration of Warrants
-
Spinach® is the Number One Vape Brand in Canada
-
Brixton Metals Commences 2026 Thorn Project Exploration Program
-
Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program
-
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
-
Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference
-
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
-
zerohash Adds Support for HYPE, USDC.HYPE, and USDT.HYPE, Expanding Access for One of the Fastest-Growing Technology Ecosystems
-
Swarmer Publishes Letter From Its Chairman, Erik Prince, Outlining Strategy
-
Quantum Cyber Entering Steady-State Scale Production, Launches Vertically Integrated Advanced Filament Manufacturing Division
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
In tomorrow’s AI economy, what’s the role of humans?
-
Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026
-
Toobit Rewards Traders with VIP Benefits and Over 1,000 USDT
-
The World Cup Effect: Superprof Survey Finds American Families Are Getting Excited About World Cultures
-
Labrador Gold to Host Investor Webinar on the Mariposa Gold Project in Yukon’s White Gold District
-
Kyivstar’s Uklon Launches Marketplace, Starting with Flower Delivery
-
Xali Gold Announces Non-Brokered Financing
-
Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy
-
Joveo Named Strategic Challenger on 2026 Fosway 9-Grid™ for Talent Acquisition
-
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
-
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
-
Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Cl
-
Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms
-
Troilus Continues to Expand High-Grade West Rim Discovery With 19.06 g/t AuEQ Over 6.4 m and 6.81 g/t AuEQ Over 5 m at Surface
-
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
-
GURU Organic Energy Delivers 31.6% Revenue Growth and Continued Margin Expansion in Second Quarter 2026
-
Lithium Ionic Initiates Long-Lead Order and Provides Community Engagement Update
